Grand Rounds, April 9, 2025

April 8, 2026

Presentation Title: The Ethical Imperative to Find Equipoise in the Transplant Candidate Selection Process

Speaker: Ty S. Diwan, MD, Transplant Surgeon, Mayo Clinic

Date: Thursday, April 9, 2025
Time: 7:00 AM ‐ 8:00 AM
Location: Medical School Building
Learning Format: In‐Person

Learning Objectives:
At the conclusion of this activity, participants should be able to:

  • Discuss the origins of the selection committee
  • Introduce ethical frameworks and their relationship to recipient selection
  • Explore best practices across other disciplines to improve our selection process

Credit Designation:

  • McGovern Medical School at the University of Texas Health Science Center at Houston designates this live activity for 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABS MOC Statement:

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement (s) of the American Board of Surgery’s Continuous Certification program.  It is the CME activity provider’s responsibility to submit learner completion information to ACGME for the purpose of granting ABS credit.

Event Disclosures:

Speaker:
Tayyab Diwan, MD,  Professor of Surgery, Surgical Director – Kidney and Pancreas Transplant Program, Mayo Clinic has no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Planners and other Administrative Support: David Wainwright, MD, Sasha D. Adams, MD, Acute Care Surgery Program Director, General Surgery Residency Vice-Chair for Education, Department of Surgery, Lillian Kao, MD, Professor, Surgery, Natalie Drucker, MD and Tamara Saunders, MD have no financial relationship(s) with ineligible companies who primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Mark Hobeika, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:TransMedics, Inc – Contracted Research – Relationship Ended

Steven Canfield, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:AngioDynamics – Advisory Committee Member – Relationship Has Not Ended

Erik Wilson, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:Johnson & Johnson – Teaching – Relationship Has Not Ended

  • Gore – Teaching – Relationship Has Not Ended
  • Medtronic – Teaching – Relationship Has Not Ended
  • GI Windows – Independent Contractor – Relationship Has Not Ended
  • Boston Scientific – Teaching – Relationship Has Not Ended

Laura Moore, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:Frontline Medical Technologies – Advisory Committee Member – Relationship Has Not Ended

Shinil Shah, DO has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:GI Windows – Contracted Research – Relationship Has Not Ended

 

Related topics